Nov 3, 2023
January 26, 2025
This week’s newsletter included:
-
Utah Business: Introducing the 2023 Innovation Awards Honorees
-
US-Israeli Biotech Progresses Tree Toxin in Phase I
-
BD Introduces Technology to Drive First-Stick Success for IV Insertions
-
Seek Labs Innovation Day
-
Center for Medical Innovation Relocates to The Shop SLC
-
Myriad Genetics Appoints Sam Raha as Chief Operating Officer
-
Sorriso Pharmaceuticals: First Subject Dosed in Phase 1/1b Clinical Trial
-
ATL Announces New VP of Human Resources
-
Rare Disease Advocates in the Spotlight
Featured New Member: Lumipen Pro
Recent News
- Webinar Recap: Immigration Compliance Under Pressure
- bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies
- DGENTHERA AND NUSANO SIGN LETTER OF INTENT FOR ASTATINE‑211 SUPPLY
- 2025 BIO International Recap
- Halia Therapeutics Completes First-in-Human Phase 1 Study of HT-4253, a Novel LRRK2 Inhibitor Targeting Neuroinflammation
- Nelson Labs to Double Cleanroom Capacity to Support Growing Demand for Sterility Assurance Services